Skip to main content
Explore URMC
URMC / Medicine / Infectious Diseases / News and Events

News and Events


Ann Falsey's Study Shows 80 Percent Effectiveness of RSV Vaccine for Older Adults

Thursday, February 16, 2023

Ann Falsey, M.D., professor of Medicine in infectious diseases and co-director of the URMC Vaccine and Treatment Evaluation Unit, is lead author of a recent New England Journal of Medicine paper based on a phase 2b clinical trial of the Janssen adult RSV vaccine. Falsey's research is among the first breakthroughs toward a safe and effective vaccine. With these results, Janssen has initiated its phase 3 trials with Falsey in an advisory role.

Read the full article (subscription required).

More News from the Newsroom